{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:31:49Z","timestamp":1793946709277,"version":"4.8.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,24]],"date-time":"2027-04-24T00:00:00Z","timestamp":1808524800000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM137901"],"award-info":[{"award-number":["R35GM137901"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB031830"],"award-info":[{"award-number":["R01EB031830"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA276240"],"award-info":[{"award-number":["R01CA276240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118676","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:28:33Z","timestamp":1776871713000},"page":"118676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control"],"prefix":"10.1016","volume":"138","author":[{"given":"Zeyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad J.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan R.","family":"Fayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118676_bb0005","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.str.2005.05.012","article-title":"Crystal structure of human CD38 extracellular domain","volume":"13","author":"Liu","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2026.118676_bb0010","doi-asserted-by":"crossref","first-page":"32861","DOI":"10.1074\/jbc.M606365200","article-title":"Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis","volume":"281","author":"Liu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0092-8674(81)90441-4","article-title":"Biochemical studies of the human thymocyte cell-surface antigens t6, t9 and t10","volume":"23","author":"Terhorst","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118676_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-1229(87)90085-7","article-title":"Thymic hormone modulation of CD38 (t10) antigen on human cord blood lymphocytes","volume":"45","author":"Gerli","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.bmc.2026.118676_bb0025","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.4049\/jimmunol.144.7.2811","article-title":"Isolation of a cDNA encoding the human CD38 (t10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation","volume":"144","author":"Jackson","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V88.4.1365.bloodjournal8841365","article-title":"CD38 expression distinguishes two groups of b-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis","volume":"88","author":"Zupo","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1096\/fasebj.12.7.581","article-title":"CD38 is functionally dependent on the TCR\/CD3 complex in human t cells","volume":"12","author":"Morra","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118676_bb0040","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.V99.7.2490","article-title":"Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells","volume":"99","author":"Deaglio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0045","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1073\/pnas.050583197","article-title":"CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation","volume":"97","author":"Zilber","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118676_bb0050","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V99.6.2154","article-title":"The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression","volume":"99","author":"Medina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0055","doi-asserted-by":"crossref","first-page":"30045","DOI":"10.1074\/jbc.270.50.30045","article-title":"Regulatory role of CD38 (ADP-ribosyl cyclase\/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice","volume":"270","author":"Kato","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0060","doi-asserted-by":"crossref","first-page":"C297","DOI":"10.1152\/ajpcell.00139.2017","article-title":"Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion","volume":"314","author":"Boslett","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bmc.2026.118676_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.202109-2151OC","article-title":"CD38 mediates lung fibrosis by promoting alveolar epithelial cell aging","volume":"206","author":"Cui","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"Pt 3","key":"10.1016\/j.bmc.2026.118676_bb0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1042\/bj3301129","article-title":"CD38 binding to human myeloid cells is mediated by mouse and human CD31","volume":"330","author":"Horenstein","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2026.118676_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1096\/fasebj.13.2.273","article-title":"Ligand-induced internalization of CD38 results in intracellular ca2+ mobilization: role of NAD+ transport across cell membranes","volume":"13","author":"Zocchi","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118676_bb0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.159.1.184","article-title":"CD38 ligation in human b cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase","volume":"159","author":"Kitanaka","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.159.1.193","article-title":"CD38 ligation results in activation of the raf-1\/mitogen-activated protein kinase and the CD3-zeta\/zeta-associated protein-70 signaling pathways in jurkat t lymphocytes","volume":"159","author":"Zubiaur","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0090","doi-asserted-by":"crossref","first-page":"20633","DOI":"10.1074\/jbc.274.29.20633","article-title":"The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in jurkat t cells","volume":"274","author":"Zubiaur","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/13.4.397","article-title":"Signaling through CD38 induces NK cell activation","volume":"13","author":"Mallone","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/eji.200636453","article-title":"CD38 cross-linking enhances TLR-induced b cell proliferation but decreases IgM plasma cell differentiation","volume":"37","author":"Manjarrez-Ordu\u00f1o","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0105","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.bbamcr.2014.10.028","article-title":"Determinants of the membrane orientation of a calcium signaling enzyme CD38","volume":"1853","author":"Zhao","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2026.118676_bb0110","doi-asserted-by":"crossref","first-page":"ra67","DOI":"10.1126\/scisignal.2002700","article-title":"The membrane-bound enzyme CD38 exists in two opposing orientations","volume":"5","author":"Zhao","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.bmc.2026.118676_bb0115","doi-asserted-by":"crossref","first-page":"30327","DOI":"10.1074\/jbc.270.51.30327","article-title":"ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP","volume":"270","author":"Aarhus","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0120","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1096\/fasebj.12.14.1507","article-title":"The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes","volume":"12","author":"Franco","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118676_bb0125","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.8235624","article-title":"Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38","volume":"262","author":"Howard","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118676_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2119\/2006-00086.Lee","article-title":"Structure and enzymatic functions of human CD38","volume":"12","author":"Lee","year":"2006","journal-title":"Mol Med"},{"key":"10.1016\/j.bmc.2026.118676_bb0135","doi-asserted-by":"crossref","first-page":"21566","DOI":"10.1074\/jbc.M909365199","article-title":"Identification of the enzymatic active site of CD38 by site-directed mutagenesis","volume":"275","author":"Munshi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0140","doi-asserted-by":"crossref","first-page":"7855","DOI":"10.1021\/ja001139c","article-title":"A covalent intermediate in CD38 is responsible for ADP-Ribosylation and cyclization reactions","volume":"122","author":"Sauve","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118676_bb0145","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1074\/jbc.M609093200","article-title":"Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38","volume":"282","author":"Liu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0150","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.chembiol.2008.08.007","article-title":"Covalent and noncovalent intermediates of an NAD utilizing enzyme, human CD38","volume":"15","author":"Liu","year":"2008","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2026.118676_bb0155","doi-asserted-by":"crossref","first-page":"27637","DOI":"10.1074\/jbc.M109.031005","article-title":"Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2006.05.100","article-title":"Decreased cADPR and increased NAD+ in the cd38\u2212\/\u2212 mouse","volume":"346","author":"Young","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0165","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0170","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1074\/jbc.RA118.005844","article-title":"A cytosolic chaperone complex controls folding and degradation of type III CD38","volume":"294","author":"Wu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0175","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1073\/pnas.1703718114","article-title":"Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels","volume":"114","author":"Liu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118676_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1166\/msr.2014.1031","article-title":"The type III calcium signaling mechanism of CD38","volume":"3","author":"Lee","year":"2014","journal-title":"Messenger"},{"key":"10.1016\/j.bmc.2026.118676_bb0185","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.REV119.009635","article-title":"Resolving the topological enigma in ca(2+) signaling by cyclic ADP-ribose and NAADP","volume":"294","author":"Lee","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0190","doi-asserted-by":"crossref","first-page":"ra23","DOI":"10.1126\/scisignal.2000278","article-title":"TRPM2 functions as a lysosomal ca2+\u2212release channel in beta cells","volume":"2","author":"Lange","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.bmc.2026.118676_bb0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.pharmtox.41.1.317","article-title":"Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers","volume":"41","author":"Lee","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2026.118676_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: an immunomodulatory molecule in inflammation and autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0205","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1096\/fasebj.10.12.8903511","article-title":"Human CD38, a cell-surface protein with multiple functions","volume":"10","author":"Mehta","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118676_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101902","article-title":"Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis","volume":"24","author":"Shi","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2026.118676_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/138161209787185788","article-title":"CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions","volume":"15","author":"Chini","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2026.118676_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","article-title":"CD38-NAD(+)Axis regulates immunotherapeutic anti-tumor t cell response","volume":"27","author":"Chatterjee","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmc.2026.118676_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13551","article-title":"Nicotinamide adenine dinucleotide: biosynthesis, consumption and therapeutic role in cardiac diseases","volume":"231","author":"Tannous","year":"2021","journal-title":"Acta Physiol"},{"key":"10.1016\/j.bmc.2026.118676_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113395","article-title":"CD38: an important regulator of t cell function","volume":"153","author":"Li","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2026.118676_bb0235","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.bmc.2026.118676_bb0240","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118676_bb0245","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.bmc.2026.118676_bb0250","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.chembiol.2003.11.011","article-title":"NAD biosynthesis: identification of the tryptophan to quinolinate pathway in bacteria","volume":"10","author":"Kurnasov","year":"2003","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2026.118676_bb0255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118676_bb0260","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0006-291X(02)02285-4","article-title":"Identification of a novel human nicotinamide mononucleotide adenylyltransferase","volume":"297","author":"Raffaelli","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0265","doi-asserted-by":"crossref","first-page":"50754","DOI":"10.1074\/jbc.M408388200","article-title":"The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates sir2 activity in mammalian cells","volume":"279","author":"Revollo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0270","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.1074\/jbc.M111469200","article-title":"Structure of human nicotinamide\/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0275","doi-asserted-by":"crossref","first-page":"15456","DOI":"10.1021\/bi011858j","article-title":"Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions","volume":"40","author":"Sauve","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2026.118676_bb0280","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1039\/D1SC06256E","article-title":"Discovery of an NAD(+) analogue with enhanced specificity for PARP1","volume":"13","author":"Zhang","year":"2022","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2026.118676_bb0285","doi-asserted-by":"crossref","first-page":"21767","DOI":"10.1074\/jbc.M110.213298","article-title":"Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation","volume":"286","author":"Nikiforov","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0290","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmc.2026.118676_bb0295","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1073\/pnas.1417921112","article-title":"In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1081\u20131095","key":"10.1016\/j.bmc.2026.118676_bb0300","article-title":"A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD(+) decline","volume":"27","author":"Tarrago","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmc.2026.118676_bb0305","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13589","article-title":"CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging","volume":"21","author":"Peclat","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.bmc.2026.118676_bb0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.24425","article-title":"Alzheimer\u2019s disease pathology is attenuated in a CD38-deficient mouse model","volume":"78","author":"Blacher","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bmc.2026.118676_bb0315","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jnc.15367","article-title":"Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD","volume":"158","author":"Roboon","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2026.118676_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2018.02.015","article-title":"Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides","volume":"118","author":"Boslett","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bmc.2026.118676_bb0325","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood.V87.6.2308.bloodjournal8762308","article-title":"Expression of cyclic ADP-ribose-synthetizing CD38 molecule on human platelet membrane","volume":"87","author":"Ramaschi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0330","doi-asserted-by":"crossref","first-page":"56598","DOI":"10.18632\/oncotarget.17896","article-title":"Expression of CD38 in myeloma bone niche: a rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation","volume":"8","author":"Costa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2026.118676_bb0335","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3324\/haematol.2018.192757","article-title":"CD38 as a therapeutic target for adult acute myeloid leukemia and t-cell acute lymphoblastic leukemia","volume":"104","author":"Naik","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bmc.2026.118676_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in b-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0345","first-page":"8","article-title":"Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade","author":"Yang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bmc.2026.118676_bb0350","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2119\/molmed.2016.00198","article-title":"Adenosine generated in the bone marrow niche through a CD38-mediated pathway correlates with progression of human myeloma","volume":"22","author":"Horenstein","year":"2016","journal-title":"Mol Med"},{"key":"10.1016\/j.bmc.2026.118676_bb0355","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118676_bb0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2021.03.001","article-title":"Targeted knockdown of the adenosine a(2A) receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory t cells","volume":"21","author":"Newton","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bmc.2026.118676_bb0365","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000561","article-title":"Bone marrow mesenchymal stromal cell-mediated resistance in multiple myeloma against NK cells can be overcome by introduction of CD38-CAR or TRAIL-variant","volume":"5","author":"Holthof","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.bmc.2026.118676_bb0370","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2003-03-0989","article-title":"CD38 is a signaling molecule in b-cell chronic lymphocytic leukemia cells","volume":"102","author":"Deaglio","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0375","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0380","article-title":"CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity","volume":"32","author":"Imbery","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.bmc.2026.118676_bb0385","doi-asserted-by":"crossref","first-page":"22062","DOI":"10.1038\/s41598-021-01300-8","article-title":"Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis","volume":"11","author":"Farber","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118676_bb0390","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","article-title":"Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors","volume":"186","author":"de Weers","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0395","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMoa1606038","article-title":"Daratumumab, bortezomib, and dexamethasone for multiple myeloma","volume":"375","author":"Palumbo","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118676_bb0400","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1486948","article-title":"Daratumumab induces CD38 internalization and impairs myeloma cell adhesion","volume":"7","author":"Ghose","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bmc.2026.118676_bb0405","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-18-1597","article-title":"The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myeloma","volume":"25","author":"Moreno","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2026.118676_bb0410","doi-asserted-by":"crossref","first-page":"25602","DOI":"10.18632\/oncotarget.4693","article-title":"A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of t cell proliferation","volume":"6","author":"Morandi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2026.118676_bb0415","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade","volume":"8","author":"Chen","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bmc.2026.118676_bb0420","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41419-021-03968-2","article-title":"The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2026.118676_bb0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-024-03881-5","article-title":"High CD38 expression defines a mitochondrial function-adapted CD8(+) t cell subset with implications for lung cancer immunotherapy","volume":"74","author":"Lv","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bmc.2026.118676_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000987","article-title":"Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1\/PD-L1 immunotherapy in hepatocellular carcinoma","volume":"8","author":"Ng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bmc.2026.118676_bb0435","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s43587-023-00532-9","article-title":"NADase CD38 is a key determinant of ovarian aging","volume":"4","author":"Yang","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.bmc.2026.118676_bb0440","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","article-title":"Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages","volume":"2","author":"Covarrubias","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.bmc.2026.118676_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114102","article-title":"LXR\/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD(+) depletion","volume":"43","author":"Terao","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmc.2026.118676_bb0450","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2006.08.066","article-title":"Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38","volume":"349","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0455","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3389\/fimmu.2018.01593","article-title":"CD38 is robustly induced in human macrophages and monocytes in inflammatory conditions","volume":"9","author":"Amici","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2026.118676_bb0460","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cellsig.2017.10.014","article-title":"Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-\u03baB signaling suppression","volume":"42","author":"Shu","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.bmc.2026.118676_bb0465","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood.2019004332","article-title":"The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications","volume":"136","author":"Ogiya","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2026.118676_bb0470","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2019.03.199","article-title":"The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD(+) decline","volume":"513","author":"Chini","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0475","doi-asserted-by":"crossref","unstructured":"Cole, S.; Walsh, A.; Yin, X.; Wechalekar, M. D.; Smith, M. D.; Proudman, S. M.; Veale, D. J.; Fearon, U.; Pitzalis, C.; Humby, F.; Bombardieri, M.; Axel, A.; Adams, H., 3rd; Chiu, C.; Sharp, M.; Alvarez, J.; Anderson, I.; Madakamutil, L.; Nagpal, S.; Guo, Y., Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2018, 20, 85.","DOI":"10.1186\/s13075-018-1578-z"},{"key":"10.1016\/j.bmc.2026.118676_bb0480","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-lived plasma cells are contained within the CD19(\u2212)CD38(hi)CD138(+) subset in human bone marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.bmc.2026.118676_bb0485","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/107999099313299","article-title":"Upregulation of CD38 gene expression in leukemic b cells by interferon types i and II","volume":"19","author":"Bauvois","year":"1999","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.bmc.2026.118676_bb0490","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/ijms22052424","article-title":"Dysregulated CD38 expression on peripheral blood immune cell subsets in SLE","volume":"22","author":"Burns","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118676_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-015-0551-3","article-title":"Long-lived plasma cells are early and constantly generated in New Zealand black\/New Zealand white f1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors","volume":"17","author":"Taddeo","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bmc.2026.118676_bb0500","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","article-title":"The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus","volume":"74","author":"Alexander","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bmc.2026.118676_bb0505","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","article-title":"The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 t cell function and identifies patients with SLE prone to infections","volume":"30","author":"Katsuyama","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmc.2026.118676_bb0510","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1038\/s41467-024-52617-7","article-title":"CD38 in SLE CD4 t cells promotes ca(2+) flux and suppresses interleukin-2 production by enhancing the expression of GM2 on the surface membrane","volume":"15","author":"Katsuyama","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0515","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with daratumumab in refractory systemic lupus erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118676_bb0520","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41591-023-02479-1","article-title":"Daratumumab monotherapy for refractory lupus nephritis","volume":"29","author":"Roccatello","year":"2023","journal-title":"Nat Med"},{"issue":"Pt 3","key":"10.1016\/j.bmc.2026.118676_bb0525","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1042\/bj3301383","article-title":"Human CD38 is an authentic NAD(P)+ glycohydrolase","volume":"330","author":"Berthelier","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2026.118676_bb0530","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1021\/jo00011a029","article-title":"Pyridine coenzyme analogs. 3. Synthesis of three NAD+ analogs containing a 2\u2032-deoxy-2\u2032-substituted nicotinamide arabinofuranosyl moiety","volume":"56","author":"Sleath","year":"1991","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0535","doi-asserted-by":"crossref","first-page":"eaba6752","DOI":"10.1126\/sciadv.aba6752","article-title":"Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases","volume":"6","author":"Dai","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmc.2026.118676_bb0540","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2021.06.041","article-title":"Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy","volume":"336","author":"Dai","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.bmc.2026.118676_bb0545","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41467-025-67661-0","article-title":"A versatile platform for chemical engineering of exosomes empowered by ADP-ribosyl cyclases","volume":"17","author":"Zhang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118676_bb0550","doi-asserted-by":"crossref","DOI":"10.4028\/b-u9QtX5","article-title":"Synthesis of bispecific conjugates by ADP-Ribosyl cyclases","volume":"13","author":"Kim","year":"2026","journal-title":"Adv Sci"},{"key":"10.1016\/j.bmc.2026.118676_bb0555","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1021\/bi201509f","article-title":"Catalysis-based inhibitors of the calcium signaling function of CD38","volume":"51","author":"Kwong","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2026.118676_bb0560","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2026.118676_bb0565","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1021\/ja411046j","article-title":"Revealing CD38 cellular localization using a cell permeable, mechanism-based fluorescent small-molecule probe","volume":"136","author":"Shrimp","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118676_bb0570","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1021\/jacsau.4c00695","article-title":"Nicotinamide riboside and CD38: covalent inhibition and live-cell labeling","volume":"4","author":"Kao","year":"2024","journal-title":"JACS Au"},{"issue":"Pt 3","key":"10.1016\/j.bmc.2026.118676_bb0575","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj3350631","article-title":"Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues","volume":"335","author":"Wall","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2026.118676_bb0580","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/bi00401a028","article-title":"Carbanicotinamide adenine dinucleotide: synthesis and enzymological properties of a carbocyclic analogue of oxidized nicotinamide adenine dinucleotide","volume":"27","author":"Slama","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2026.118676_bb0585","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1039\/C8SC03899F","article-title":"Facile chemoenzymatic synthesis of a novel stable mimic of NAD","volume":"9","author":"Dai","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2026.118676_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/cpnc.83","article-title":"Chemoenzymatic preparation of 4\u2019-Thioribose NAD","volume":"77","author":"Zhang","year":"2019","journal-title":"Curr Protoc Nucleic Acid Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0595","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3390\/molecules26237165","article-title":"Small molecule CD38 inhibitors: synthesis of 8-amino-N1-inosine 5\u2032-monophosphate, analogues and early structure-activity relationship","volume":"26","author":"Watt","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118676_bb0600","doi-asserted-by":"crossref","unstructured":"Haffner, C. D.; Becherer, J. D.; Boros, E. E.; Cadilla, R.; Carpenter, T.; Cowan, D.; Deaton, D. N.; Guo, Y.; Harrington, W.; Henke, B. R.; Jeune, M. R.; Kaldor, I.; Milliken, N.; Petrov, K. G.; Preugschat, F.; Schulte, C.; Shearer, B. G.; Shearer, T.; Smalley, T. L., Jr.; Stewart, E. L.; Stuart, J. D.; Ulrich, J. C., Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors. J Med Chem 2015, 58, 3548\u201371.","DOI":"10.1021\/jm502009h"},{"key":"10.1016\/j.bmc.2026.118676_bb0605","doi-asserted-by":"crossref","unstructured":"Becherer, J. D.; Boros, E. E.; Carpenter, T. Y.; Cowan, D. J.; Deaton, D. N.; Haffner, C. D.; Jeune, M. R.; Kaldor, I. W.; Poole, J. C.; Preugschat, F.; Rheault, T. R.; Schulte, C. A.; Shearer, B. G.; Shearer, T. W.; Shewchuk, L. M.; Smalley, T. L., Jr.; Stewart, E. L.; Stuart, J. D.; Ulrich, J. C., Discovery of 4-Amino-8-quinoline carboxamides as novel, submicromolar inhibitors of NAD-hydrolyzing enzyme CD38. J Med Chem 2015, 58, 7021\u201356.","DOI":"10.1021\/acs.jmedchem.5b00992"},{"key":"10.1016\/j.bmc.2026.118676_bb0610","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/acs.jmedchem.2c00688","article-title":"Orally bioavailable enzymatic inhibitor of CD38, MK-0159, protects against ischemia\/reperfusion injury in the murine heart","volume":"65","author":"Lagu","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0615","article-title":"Heterobicyclic amides as inhibitors of CD38","author":"Schenkel","year":"2022","journal-title":"US11535621B2"},{"key":"10.1016\/j.bmc.2026.118676_bb0620","article-title":"Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism","volume":"5","author":"Huang","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.bmc.2026.118676_bb0625","doi-asserted-by":"crossref","first-page":"12762","DOI":"10.1021\/acs.jmedchem.3c00391","article-title":"Discovery of a first-in-Class CD38 inhibitor for the treatment of mitochondrial myopathy","volume":"66","author":"Li","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0630","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1039\/c0ob00768d","article-title":"Design, synthesis and biological characterization of novel inhibitors of CD38","volume":"9","author":"Dong","year":"2011","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2026.118676_bb0635","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cmdc.201100487","article-title":"Design, synthesis and biological evaluation of noncovalent inhibitors of human CD38 NADase","volume":"7","author":"Zhou","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118676_bb0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.apsb.2013.05.003","article-title":"Synthesis and activity of novel indole derivatives as inhibitors of CD38","volume":"3","author":"Wu","year":"2013","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118676_bb0645","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/cbic.201900169","article-title":"Rational design and identification of small-molecule allosteric inhibitors of CD38","volume":"20","author":"Yang","year":"2019","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2026.118676_bb0650","doi-asserted-by":"crossref","first-page":"33260","DOI":"10.1039\/D1RA06266B","article-title":"Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation","volume":"11","author":"Benton","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2026.118676_bb0655","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96962","article-title":"Functional identification of soluble uric acid as an endogenous inhibitor of CD38","volume":"13","author":"Wen","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2026.118676_bb0660","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.bmcl.2011.05.022","article-title":"Flavonoids as inhibitors of human CD38","volume":"21","author":"Kellenberger","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118676_bb0665","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db12-1139","article-title":"Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome","volume":"62","author":"Escande","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bmc.2026.118676_bb0670","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/ijc.29095","article-title":"Inhibition of glioma progression by a newly discovered CD38 inhibitor","volume":"136","author":"Blacher","year":"2015","journal-title":"Int J Cancer"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:00:40Z","timestamp":1793944840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962600132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":134,"alternative-id":["S096808962600132X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118676","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118676"}}